The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Hollatz competitive analysis

Loading summary...

Latest oppositions filed by Hollatz

Explore patent oppositions filed by Hollatz against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3628319
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
EP3191461
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
EP2350096
Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSSep 11, 2020
EP3272361
Method For Producing A Freeze-Dried Pharmaceutical Composition Containing Mitomycin CMEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATEAug 20, 2020
EP2802562
Process For The Preparation Of TravoprostCHINOIN GYGYSZER S VEGYSZETI TERMKEK GYRA ZRTOct 23, 2019
EP2665680
Method For Obtaining Elements Or Element Compounds From The Intermediate Products Or By-Products Obtained During The Production Of Titanium DioxideHUNTSMAN P&A UERDINGENJul 18, 2018

Latest PTAB cases involving Hollatz

Discover the latest PTAB cases involving Hollatz, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hollatz with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HOLLATZ6 - - -
EUROAPI HUNGARY LIABILITY - 1 - -
HUNTSMAN P&A UERDINGEN - 1 - -
SALIX PHARMACEUTICALS - 17 - 3